Company Overview of OCTIMET Oncology NV
OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded in 2016 and is headquartered in Beerse, Belgium.
Founded in 2016
32 473 558 353
Key Executives for OCTIMET Oncology NV
Similar Private Companies By Industry
|ADx NeuroSciences NV||Europe|
|Apitope International NV||Europe|
Recent Private Companies Transactions
January 18, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact OCTIMET Oncology NV, please visit www.octimet.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.